Larotrectinib long-term efficacy and safety in adult patients (pts) with tropomyosin receptor kinase (TRK) fusion Cancer Meeting Abstract


Authors: Rieke, D. T.; Hong, D. S.; Drilon, A.; Tan, D. S.; Lin, J.; Kummar, S.; McDermott, R.; Berlin, J.; Italiano, A.; Lassen, U. N.; Leyvraz, S.; Tahara, M.; Norenberg, R.; Burcoveanu, D. I.; Brega, N.; Shen, L.
Abstract Title: Larotrectinib long-term efficacy and safety in adult patients (pts) with tropomyosin receptor kinase (TRK) fusion Cancer
Meeting Title: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (2023)
Journal Title: Oncology Research and Treatment
Volume: 46
Issue: Suppl. 5
Meeting Dates: 2023 Oct 13-16
Meeting Location: Hamburg, Germany
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2023-10-01
Start Page: 142
End Page: 143
Language: English
ACCESSION: WOS:001091456900314
PROVIDER: wos
PUBMED: 37788643
DOI: 10.1159/000533576
Notes: Meeting Abstract: V969 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    636 Drilon